Clinical Trial Update: Prevenar (13v) Infant Drug Use Investigation

View source ↗

Summary

A completed infant-use clinical trial of Pfizer's Prevnar 13 vaccine with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• Prevnar 13 (pneumococcal conjugate vaccine)

Snippet

Sponsor: Pfizer | Conditions: Infants | Status: COMPLETED | Results posted: 2017-06-19